Remote Participation (Within USA) Trial of Sana Pain Reliever

ID#: NCT04280562

Age: 18 years - 66+

Gender: All

Healthy Subjects: No

Study Phase: N/A

Recruitment Status: Recruiting

Start Date: January 16, 2020

End Date: January 01, 2022

Contact Information:
Laura Tabacof, MD
2122418545
Patrycja Graczyk
(929) 618-0583
Summary: Randomized controlled trial to assess the effectiveness and patient perception of the benefit of the Sana Pain Reliever in individuals with chronic neuropathic pain.The study is fully remote with four study visits taking place over teleconferencing and the study devices mailed to the participants to use at home for 8-14 weeks.
Eligibility:

Inclusion Criteria:

- Confirmed clinical diagnosis of neuropathic pain

- Age of 18 years or older at time of consent

- Fluent in English

- Consistent medications for the last 4 weeks prior to the first baseline visit (week 0)

Exclusion Criteria:

- Diagnosis of photosensitive epilepsy

- Active ear or eye infection

- Vision impairments that affect perception of light in one or both eyes

- Deafness in one or both ears

- Severe depression (Score higher than 30 points on the Beck's Depression Inventory)